Mersana Therapeutics Inc
MRSN
Market Cap$312.54M
Close$
$-1.22
148.2% downside
Current Fair Value
148.2% downsideOvervalued by 148.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $312.54 Million |
|---|---|
| Enterprise Value | $296.55 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.48 |
| Beta | 1.48 |
| Outstanding Shares | 122,721,918 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -4.16 |
|---|---|
| PEG | 5.75 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 8.51 |
| Enterprise Value to EBIT | -4.45 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 59.94 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Mersana Therapeutics Inc
CEO: Anna Protopapas